Atai Life Sciences N.V. (ETR:9VC)
Germany
· Delayed Price · Currency is EUR 1.938
+0.012 (0.62%)
At close: May 30, 2025, 5:30 PM CET
Atai Life Sciences Market Cap
Atai Life Sciences has a market cap or net worth of €413.78 million as of June 5, 2025. Its market cap has increased by 44.44% in one year.
Market Cap
413.78M
Enterprise Value
353.12M
Revenue
1.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.94
Market Cap Chart
Since June 18, 2021, Atai Life Sciences's market cap has decreased from 2.50B to 413.78M, a decrease of -83.47%. That is a compound annual growth rate of -36.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2025 | 413.78M | 91.95% |
| Dec 31, 2024 | 215.57M | 1.79% |
| Dec 29, 2023 | 211.77M | -48.71% |
| Dec 30, 2022 | 412.86M | -61.61% |
| Dec 31, 2021 | 1.08B | -57.03% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Siemens Healthineers AG | 51.98B |
| Merck KGaA | 50.22B |
| Fresenius SE & Co. KGaA | 24.32B |
| Bayer Aktiengesellschaft | 24.30B |
| Fresenius Medical Care AG | 14.68B |
| Sartorius Aktiengesellschaft | 13.25B |
| Carl Zeiss Meditec AG | 4.98B |
| Fielmann Group AG | 4.70B |